The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C08 | Calcium channel blockers | |
| 3 | C08C | Selective calcium channel blockers with mainly vascular effects | |
| 4 | C08CA | Dihydropyridine derivatives | |
| 5 | C08CA17 |
| Active Ingredient | Description | |
|---|---|---|
| Levamlodipine |
Levamlodipine is the pharmacologically active isomer of amlodipine, a long-acting calcium channel blocker. It is used for the treatment of hypertension in adults and pediatric patients, to lower blood pressure. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CONJUPRI Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
